Wellness

Consenting for treatment in advance to reduce leaving the hospital against medical advice among patients with addiction – Experts debate pros and cons

January 22, 2021 – Patients with substance use disorders (SUDs) being treated for serious medical conditions are more likely to leave the hospital against medical advice (AMA) than those without addiction. A special type of contract with healthcare providers might enable patients to consent in advance to life-saving medical care – even if they later…

Investigating new treatment for schizophrenia as first Psychiatry Consortium funded project announce

A partnership between the University of Oxford, Earlham Institute (EI), and global pharmaceutical companies Biogen Inc and Boehringer Ingelheim will investigate a promising new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical companies, and two…

New perspectives challenge the idea that saturated fats cause heart disease

In science, sometimes a new perspective can turn our interpretation of the data upside-down, and necessitate a paradigm shift. There has been, and continues to be, fierce disagreements in nutrition science as to what constitutes a healthy diet. A key controversy is the role of saturated fats in health and disease. Saturated fats are known…

Patients of Asian and black backgrounds more likely to die from COVID, large study reveals

Patients of Asian and black backgrounds suffered disproportionate rates of premature death from COVID-19, according to a study of 1,737 patients by Queen Mary University of London and Barts Health NHS Trust. The study, published in BMJ Open, is one of the most comprehensive studies exploring COVID-19 outcomes in black, Asian and minority ethnic populations…

Research shows preference for male children is declining in Bangladesh

Research from the University of Kent has demonstrated a decline in ‘son preference’ by women of childbearing age in Bangladesh. However, the study also shows that fertility decisions are still influenced according to son preference. The paper, ‘Is son preference disappearing from Bangladesh?’, surveyed a nationally representative sample of Bangladeshi women of childbearing age, born…

UTMB team proves potential for reducing pre-term birth by treating fetus as patient

GALVESTON, Texas – The results of a study by researchers at the University of Texas Medical Branch may pave the way for a new medicine delivery system that could reduce the incidence of pre-term labor and premature birth by allowing physicians to treat the ‘fetus as the patient’. The study has been published in Science…

Cardiovascular diseases: New computer model improves therapy

Although treatment options are constantly improving, cardiovascular diseases are still one of the most frequent causes of death in Europe. The success of the treatment varies from patient to patient and depends on the individual clinical picture, as Gernot Plank, researcher at the Institute of Biophysics at the Medical University of Graz explains using an…

Join best-selling author James Nestor on ‘breath’ and sinus health

WHAT: Chronic sinusitis is a major health problem, impacting 30 million Americans. For more than 65 years, the American Rhinologic Society (ARS) has promoted excellence in the care of patients with nose, sinus, and skullbase disorders through research, education, and advocacy. Dedicated to fostering rhinologic research and breakthrough science that advances patient care and improves…

NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests

Washington, DC – January 22, 2021 – New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. The research is important because “NSAIDs are arguably the most commonly…

Corning Life Sciences to share suite of 3D cell culture technologies at SLAS2021

CORNING, N.Y. — Corning Incorporated (NYSE: GLW) will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year’s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27. Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D…